Armstrong G D, Hollenberg M D, Bhaumick B, Bala R M, Maturo J M
Can J Biochem Cell Biol. 1983 Jul;61(7):650-6. doi: 10.1139/o83-082.
Human placental receptors for insulin and for human basic somatomedin (BSM, analogous to human insulinlike growth factor I (IGF-I] were selectively cross-link labelled with 125I-labelled insulin and BSM using disuccinimidyl suberate under conditions whereby cross-linking of 125I-labelled insulin to the BSM receptor and of 125I-labelled BSM to the insulin receptor was avoided. We have found that the cross-link-labelled receptors for insulin and BSM, present in equivalent amounts in human placenta membrane preparations, both cross-react with antibodies directed against purified rat liver insulin receptor. Compared with the human insulin receptor, the BSM receptor cross-reacted with the antireceptor antibody to a level of roughly 9%, indicating a limited sequence homology between the insulin and BSM receptors. Since both receptors are present in comparable amounts in solubilized placenta membrane preparations, we sought methods for the selective purification of both receptors from such extracts, so as to provide a basis for further comparative structural studies of the two receptors. We have observed that both receptors were adsorbed by affinity columns of insulin-agarose, in a manner that did not yield insulin receptor entirely free from the BSM receptor. As an alternative for receptor purification, we have found that immunoaffinity columns using antiligand antibody should provide a means for the selective isolation of cross-link labelled receptor from tissues in which both are present in equivalent amounts.
利用辛二酸二琥珀酰亚胺酯,在避免¹²⁵I标记的胰岛素与人体基本生长调节素(BSM,类似于人体胰岛素样生长因子I(IGF-I))受体以及¹²⁵I标记的BSM与胰岛素受体交联的条件下,对人胎盘胰岛素受体和人基本生长调节素受体进行了选择性交联标记。我们发现,人胎盘膜制剂中含量相当的胰岛素受体和BSM受体的交联标记物,均能与针对纯化大鼠肝胰岛素受体的抗体发生交叉反应。与人体胰岛素受体相比,BSM受体与抗受体抗体的交叉反应水平约为9%,这表明胰岛素受体和BSM受体之间的序列同源性有限。由于在溶解的胎盘膜制剂中这两种受体的含量相当,我们寻找从这种提取物中选择性纯化这两种受体的方法,以便为进一步比较这两种受体的结构研究提供基础。我们观察到,这两种受体都能被胰岛素-琼脂糖亲和柱吸附,但无法使胰岛素受体完全不含BSM受体。作为受体纯化的另一种方法,我们发现使用抗配体抗体的免疫亲和柱应该能够从两种受体含量相当的组织中选择性分离交联标记的受体。